"Receptors, Adrenergic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction.
| Descriptor ID |
D011941
|
| MeSH Number(s) |
D12.776.543.750.670.300.300 D12.776.543.750.695.150.300 D12.776.543.750.720.330.300
|
| Concept/Terms |
Receptors, Adrenergic- Receptors, Adrenergic
- Adrenoceptors
- Receptors, Epinephrine
- Adrenergic Receptors
- Epinephrine Receptors
- Adrenergic Receptor
- Receptor, Adrenergic
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Adrenergic".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Biogenic Amine [D12.776.543.750.670]
- Receptors, Catecholamine [D12.776.543.750.670.300]
- Receptors, Adrenergic [D12.776.543.750.670.300.300]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Catecholamine [D12.776.543.750.695.150]
- Receptors, Adrenergic [D12.776.543.750.695.150.300]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Catecholamine [D12.776.543.750.720.330]
- Receptors, Adrenergic [D12.776.543.750.720.330.300]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Adrenergic".
This graph shows the total number of publications written about "Receptors, Adrenergic" by people in this website by year, and whether "Receptors, Adrenergic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Adrenergic" by people in Profiles.
-
AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction. Circ Res. 2024 Apr 12; 134(8):1006-1022.
-
Duloxetine and Amitriptyline Reduce Neuropathic Pain by Inhibiting Primary Sensory Input to Spinal Dorsal Horn Neurons via a1- and a2-Adrenergic Receptors. ACS Chem Neurosci. 2023 04 05; 14(7):1261-1277.
-
Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. 2020 02; 578(7795):449-454.
-
Systemic ?-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of V?9Vd2 T-Cells. Front Immunol. 2019; 10:3082.
-
Adrenoceptors-New roles for old players. Br J Pharmacol. 2019 07; 176(14):2339-2342.
-
?2-adrenergic receptors in inflammation and vascular complications of diabetes. Kidney Int. 2017 07; 92(1):14-16.
-
Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity. Neuropharmacology. 2015 Mar; 90:23-32.
-
Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the a2A-adrenoceptor selective antagonist BRL44408. Eur J Pharmacol. 2014 Nov 15; 743:89-97.
-
Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling. Proc Natl Acad Sci U S A. 2014 Sep 16; 111(37):13499-504.
-
Propranolol responsiveness in vascular tumors is not determined by qualitative differences in adrenergic receptors. Otolaryngol Head Neck Surg. 2013 Nov; 149(5):772-6.